431 related articles for article (PubMed ID: 10366738)
1. NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A.
Goebel DJ; Poosch MS
Brain Res Mol Brain Res; 1999 Jun; 69(2):164-70. PubMed ID: 10366738
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.
Buller AL; Larson HC; Schneider BE; Beaton JA; Morrisett RA; Monaghan DT
J Neurosci; 1994 Sep; 14(9):5471-84. PubMed ID: 7916045
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
Buller AL; Monaghan DT
Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
[TBL] [Abstract][Full Text] [Related]
4. Molecular and pharmacological characterization of recombinant rat/mice N-methyl-D-aspartate receptor subtypes in the yeast Saccharomyces cerevisiae.
Becker J; Li Z; Noe CR
Eur J Biochem; 1998 Sep; 256(2):427-35. PubMed ID: 9760184
[TBL] [Abstract][Full Text] [Related]
5. Transient down-regulation of NMDA receptor subunit gene expression in the rat retina following NMDA-induced neurotoxicity is attenuated in the presence of the non-competitive NMDA receptor antagonist MK-801.
Goebel DJ; Poosch MS
Exp Eye Res; 2001 May; 72(5):547-58. PubMed ID: 11311046
[TBL] [Abstract][Full Text] [Related]
6. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors.
Vicini S; Wang JF; Li JH; Zhu WJ; Wang YH; Luo JH; Wolfe BB; Grayson DR
J Neurophysiol; 1998 Feb; 79(2):555-66. PubMed ID: 9463421
[TBL] [Abstract][Full Text] [Related]
7. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
8. Subunit composition of N-methyl-D-aspartate receptors in the central nervous system that contain the NR2D subunit.
Dunah AW; Luo J; Wang YH; Yasuda RP; Wolfe BB
Mol Pharmacol; 1998 Mar; 53(3):429-37. PubMed ID: 9495808
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
[TBL] [Abstract][Full Text] [Related]
10. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z
Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptor subunit phenotypes of vagal afferent neurons in nodose ganglia of the rat.
Czaja K; Ritter RC; Burns GA
J Comp Neurol; 2006 Jun; 496(6):877-85. PubMed ID: 16628619
[TBL] [Abstract][Full Text] [Related]
13. Two N-methyl-D-aspartate receptors in rat dorsal root ganglia with different subunit composition and localization.
Marvizón JC; McRoberts JA; Ennes HS; Song B; Wang X; Jinton L; Corneliussen B; Mayer EA
J Comp Neurol; 2002 May; 446(4):325-41. PubMed ID: 11954032
[TBL] [Abstract][Full Text] [Related]
14. Subunit-specific effects of poricoic acid A on NMDA receptors.
Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
[TBL] [Abstract][Full Text] [Related]
15. Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
Erreger K; Geballe MT; Kristensen A; Chen PE; Hansen KB; Lee CJ; Yuan H; Le P; Lyuboslavsky PN; Micale N; Jørgensen L; Clausen RP; Wyllie DJ; Snyder JP; Traynelis SF
Mol Pharmacol; 2007 Oct; 72(4):907-20. PubMed ID: 17622578
[TBL] [Abstract][Full Text] [Related]
16. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins.
Wenzel A; Fritschy JM; Mohler H; Benke D
J Neurochem; 1997 Feb; 68(2):469-78. PubMed ID: 9003031
[TBL] [Abstract][Full Text] [Related]
17. Cloning, functional coexpression, and pharmacological characterisation of human cDNAs encoding NMDA receptor NR1 and NR2A subunits.
Le Bourdellès B; Wafford KA; Kemp JA; Marshall G; Bain C; Wilcox AS; Sikela JM; Whiting PJ
J Neurochem; 1994 Jun; 62(6):2091-8. PubMed ID: 8189218
[TBL] [Abstract][Full Text] [Related]
18. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
Christie JM; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
[TBL] [Abstract][Full Text] [Related]
19. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina.
Brandstätter JH; Hartveit E; Sassoè-Pognetto M; Wässle H
Eur J Neurosci; 1994 Jul; 6(7):1100-12. PubMed ID: 7952290
[TBL] [Abstract][Full Text] [Related]
20. Requirement of both NR3A and NR3B subunits for dominant negative properties on Ca2+ mobilization mediated by acquired N-methyl-D-aspartate receptor channels into mitochondria.
Fukumori R; Takarada T; Nakamichi N; Kambe Y; Kawagoe H; Nakazato R; Yoneda Y
Neurochem Int; 2010 Dec; 57(7):730-7. PubMed ID: 20813147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
